---
figid: PMC3163944__JCI43428.f7
figtitle: Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome–like
  phenotype and hyperactivated MAPK signaling in humans and mice
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3163944
filename: JCI43428.f7.jpg
figlink: /pmc/articles/PMC3163944/figure/F7/
number: F7
caption: 'Overview of genes with ChIP-CHIP binding sites and differential expression.
  Three out of the four major branches of the MAPK signaling pathway are shown: ERK1/2
  (MAP2K1/2), c-Jun, and p38 (modified from KEGG pathway map 04010;  http://www.genome.jp/kegg/).
  Mutations affecting the ERK1/2 (MAP2K1/2) branch are identified in approximately
  70% of patients with Noonan syndrome (genes marked with orange stars). Note that
  genes with significant ChIP-on-CHIP bindings sites (Supplemental Table 23) are marked
  in yellow; additional significantly differentially expressed genes in the human
  cell lines are marked with red boxes.'
papertitle: Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome–like
  phenotype and hyperactivated MAPK signaling in humans and mice.
reftext: Michael Kraft, et al. J Clin Invest. 2011 Sep 1;121(9):3479-3491.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9424679
figid_alias: PMC3163944__F7
figtype: Figure
redirect_from: /figures/PMC3163944__F7
ndex: aee229d5-df01-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3163944__JCI43428.f7.html
  '@type': Dataset
  description: 'Overview of genes with ChIP-CHIP binding sites and differential expression.
    Three out of the four major branches of the MAPK signaling pathway are shown:
    ERK1/2 (MAP2K1/2), c-Jun, and p38 (modified from KEGG pathway map 04010;  http://www.genome.jp/kegg/).
    Mutations affecting the ERK1/2 (MAP2K1/2) branch are identified in approximately
    70% of patients with Noonan syndrome (genes marked with orange stars). Note that
    genes with significant ChIP-on-CHIP bindings sites (Supplemental Table 23) are
    marked in yellow; additional significantly differentially expressed genes in the
    human cell lines are marked with red boxes.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CACNG1
  - CACNG2
  - CACNG3
  - CACNG4
  - CACNG5
  - CACNG6
  - CACNG7
  - CACNG8
  - PRKX
  - RASGRP1
  - RASGRP2
  - RASGRP3
  - RASGRP4
  - NTRK2
  - NTRK1
  - SRF
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - EGF
  - EGFR
  - MAP2K2
  - GRB2
  - ELK1
  - KCNH4
  - KCNH8
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - GAB2
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - SHOC2
  - PTPN11
  - DUSP2
  - PTPN5
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PDGFRB
  - PDGFRA
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - GNA12
  - RASA2
  - STMN1
  - PPP3CA
  - PPP3CB
  - PPP3CC
  - MAPK8IP3
  - AKT1
  - AKT2
  - AKT3
  - HSPA1A
  - HSPA1B
  - FLNA
  - NFATC1
  - MAP3K1
  - NFATC3
  - MAPK8
  - MAPK9
  - MAPK10
  - JUN
  - MAP3K11
  - JUND
  - MAP3K13
  - ATF2
  - GDNF
  - MAP3K12
  - TNF
  - TNFRSF1A
  - MAP3K20
  - TP53
  - TP63
  - TP73
  - ELK4
  - MAP3K6
  - FASLG
  - FAS
  - FASN
  - DDIT3
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - DAXX
  - MAP3K5
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - MAX
  - MAP3K7
  - NR2C2
  - MEF2C
  - CD14
  - NDUFA2
  - MAPKAPK5
  - RPS6KA4
  - RPS6KA5
  - Cancer
  - Cardiomyopathy
  - Craniosynostosis
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
